R&D
Latigo’s Non-Opioid Painkiller Matches an Opioid Combo in Phase 2b Trial
LTG-001, an oral Nav1.8 blocker, eased post-surgical pain and cut opioid rescue use in a 343-patient trial published in the New England Journal of Medicine.